How habits show up in health data.
LifeOS compares member-tracked behaviors with sleep and recovery biomarkers. Some results help confirm patterns already seen in research; others reveal new signals worth studying next.
Most health research starts in controlled clinical trials, where conditions are carefully designed and behavior is observed in a narrow setting. LifeOS adds a different kind of evidence: patterns from people living their real lives, in their own routines, environments, schedules, and recovery cycles. We begin with scientific priors from existing research, then test whether those expected relationships appear in everyday data. When they do, we can strengthen confidence in known findings. When they do not, or when a new pattern appears, we can generate sharper questions for future study. This approach does not replace clinical science; it extends it. By combining prior research with large-scale, real-world behavior and biomarker signals, LifeOS can help reveal how health factors behave outside the lab.
Real-world signals from a wide member base.
LifeOS research is built from people using devices and logging habits across everyday settings, not from a single lab site. A wider footprint helps us observe how sleep, recovery, routines, and environment vary across real lives.
Filter the findings by the type of member input you want to inspect.
Pick a factor. See which biomarkers moved.
See how sleep and recovery markers tended to move when members logged each habit. Blue bars mean the marker was higher; orange bars mean it was lower.
Start with a biomarker. See the strongest linked factors.
Choose the health marker you care about, then compare which behaviors or supplements showed the largest observed movement.
High activity days stood out most on sleep duration, with ripple effects across recovery markers.
High activity days lined up with lower total sleep (-16.0%), lower REM sleep (-18.8%) and lower deep sleep (-11.7%). This does not prove the activity caused the change, but it shows where member behavior and health biomarkers moved together most clearly. We also saw movement in additional recovery markers, so this looks like a broader sleep/recovery pattern rather than a single isolated reading.
The review found that physical activity is generally linked with better sleep quality, shorter sleep latency, and modest improvements in sleep duration. LifeOS checks whether those relationships appear in real member behavior, not just controlled study settings.
Creatine showed a mixed sleep profile: more deep sleep, but not uniformly better recovery.
Creatine lined up with higher deep sleep (17.0%), lower sleep movement (-22.9%) and higher total sleep (21.5%). This is a mixed pattern, so the useful takeaway is not that creatine is broadly good or bad for sleep. It is that member-level responses may differ across sleep duration, sleep stages, and perceived recovery.
The study found that a high single dose of creatine partly improved cognitive performance during sleep deprivation. The LifeOS finding is adjacent, so we frame it as a new signal to watch rather than a confirmed sleep-stage claim.
Vitamin D3 showed a mixed recovery pattern, with HRV moving lower while sleep duration moved higher.
Vitamin D3 lined up with lower HRV (-12.1%), higher REM sleep (19.7%) and lower sleep movement (-22.7%). The pattern is mixed, which fits the broader literature: vitamin D may matter for sleep biology, but individual baseline status and timing likely change the direction of response.
The review describes vitamin D as biologically connected to sleep regulation, while noting mixed evidence across studies. LifeOS can help separate which members show a measurable sleep response and which do not.
Omega-3 users showed a longer-sleep pattern, with REM and overnight movement changing too.
Omega-3 lined up with higher total sleep (20.0%), higher REM sleep (24.1%) and higher sleep movement (36.0%). The effect sizes are attention-grabbing, but this signal should be treated as exploratory because supplement use can cluster with other healthy routines.
This research connected omega-3 status with sleep outcomes, especially in children. LifeOS's member analysis is exploratory here: it can reveal whether similar patterns appear in adult wearable data.
Vitamin C’s clearest pattern was faster sleep onset, alongside movement in sleep stages.
Vitamin C lined up with higher REM sleep (19.1%), higher sleep movement (38.8%) and higher deep sleep (15.7%). This is an early signal, not a settled clinical claim, but it gives LifeOS a concrete research question to test with more member-days.
Vitamin C has broad health relevance, but direct evidence for sleep-stage changes is limited. LifeOS should present this as exploratory until stronger benchmark research or repeated member evidence supports it.
Magnesium looked more like a recovery signal than a simple sleep-duration signal.
Magnesium lined up with higher HRV (11.3%), lower sleep latency (-22.4%) and slightly higher REM sleep (0.1%). This is not a simple sleep-aid story; it suggests magnesium may show up differently across recovery, sleep stages, and sleep timing.
The trial reported improvements in insomnia-related measures among older adults taking magnesium. LifeOS treats this as a benchmark, then checks whether magnesium logs line up with sleep and recovery movement in members.
Vitamin B12 showed an early sleep-duration and movement pattern worth retesting.
Vitamin B12 lined up with higher total sleep (18.6%), higher sleep movement (39.9%) and higher REM sleep (19.4%). Because B12 can relate to energy and circadian rhythm, LifeOS should treat this as a signal to segment carefully by timing and member baseline.
B12 has plausible links to circadian biology, but the direct sleep-biomarker evidence is not strong enough to call it confirmed. LifeOS can still flag it as a new signal if member data repeatedly points in the same direction.
Whey protein showed a mixed recovery pattern, with longer sleep but lower sleep movement.
Whey protein lined up with lower sleep movement (-31.5%), higher sleep latency (26.2%) and higher total sleep (38.0%). This mixed profile suggests protein timing and training context may matter more than the supplement alone.
Protein before sleep is better studied for overnight muscle repair than for sleep architecture. LifeOS can still investigate whether recovery-oriented members show sleep or HRV movement after protein use.
Ashwagandha’s signal clustered around REM and deep sleep quality.
Ashwagandha lined up with higher REM sleep (27.0%), higher deep sleep (21.3%) and lower sleep movement (-19.1%). The benchmark literature is promising but still developing, so LifeOS should present this as supportive evidence plus a member-level signal to keep testing.
The meta-analysis found small but meaningful improvements in sleep outcomes across randomized trials. LifeOS can test whether those effects appear in day-to-day member tracking and which biomarkers move most.
Sauna appeared as a heat-recovery signal, led by sleep latency and HRV movement.
Sauna lined up with lower sleep latency (-31.5%), lower HRV (-17.3%) and higher REM sleep (10.2%). The signal is small but interesting: it suggests heat exposure may affect sleep timing and autonomic recovery differently across members.
The review links regular sauna bathing with cardiovascular and vascular benefits. LifeOS should frame sauna findings as heat-recovery signals and keep sleep-stage claims exploratory.